Myeloma

© GettyImages/designer491

Janssen flags accelerated approval milestone in Europe for CAR-T therapy

By Jane Byrne

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) announced they will perform an accelerated assessment of the Marketing Authorization Application (MAA) for Janssen’s investigational CAR-T therapy, ciltacabtagene...

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers